It does this by: Activating beta-3 adrenergic receptors stimulates fat breakdown and mobilization Enhancing lipolysis promotes the use of stored fat as energy Inhibiting lipogenesis reduces the formation of new fat cells In early studies, researchers observed that AOD9604 may help increase fat oxidation and improve metabolic flexibility, especially in overweight or obese individuals
Very rarely, more serious reactions can occur, such as a severe allergic reaction
Metabolic Optimization Designed to complement your weight management and fitness goals by boosting metabolic efficiency
Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance
International Journal of Obesity and Related Metabolic Disorders , 25(2), 178185
Clinical trials used doses as high as 1 mg per day without safety concerns, but 300 mcg is the most commonly referenced dose in peptide medicine literature and in the investigational protocols that have been published since the formal trials concluded